INTrEPID Data Supports Expanded LVAD Medicare Coverage Request

WorldHeart expects CMS to issue by Nov. 12 a coverage decision on left-ventricular assist devices (LVAD) implanted as a destination therapy

More from Archive

More from Medtech Insight